iCAD (NASDAQ: ICAD)
iCAD Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
iCAD Company Info
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
News & Analysis
Valuation
Earnings Transcripts
iCAD (ICAD) Q2 2022 Earnings Call Transcript
ICAD earnings call for the period ending June 30, 2022.
iCAD (ICAD) Q1 2022 Earnings Call Transcript
ICAD earnings call for the period ending March 31, 2022.
iCAD (ICAD) Q4 2021 Earnings Call Transcript
ICAD earnings call for the period ending December 31, 2021.
iCAD (ICAD) Q3 2021 Earnings Call Transcript
ICAD earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.